Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. (Q46262897)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. |
scientific article |
Statements
Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation (English)
Z A Stewart
A M Cameron
A L Singer
R A Montgomery
4 November 2008